142 related articles for article (PubMed ID: 15291354)
21. Discovery of novel epigenetic markers in non-Hodgkin's lymphoma.
Shi H; Guo J; Duff DJ; Rahmatpanah F; Chitima-Matsiga R; Al-Kuhlani M; Taylor KH; Sjahputera O; Andreski M; Wooldridge JE; Caldwell CW
Carcinogenesis; 2007 Jan; 28(1):60-70. PubMed ID: 16774933
[TBL] [Abstract][Full Text] [Related]
22. Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively.
Tracey L; Pérez-Rosado A; Artiga MJ; Camacho FI; Rodríguez A; Martínez N; Ruiz-Ballesteros E; Mollejo M; Martinez B; Cuadros M; Garcia JF; Lawler M; Piris MA
J Pathol; 2005 Jun; 206(2):123-34. PubMed ID: 15880597
[TBL] [Abstract][Full Text] [Related]
23. Expression of the PIM2 gene is associated with more aggressive clinical course in patients with chronic lymphocytic leukemia.
Kapelko-Słowik K; Dybko J; Grzymajło K; Jaźwiec B; Urbaniak-Kujda D; Słowik M; Potoczek S; Wołowiec D
Adv Clin Exp Med; 2019 Mar; 28(3):385-390. PubMed ID: 30525315
[TBL] [Abstract][Full Text] [Related]
24. Optimization of quantitative real-time RT-PCR parameters for the study of lymphoid malignancies.
Lossos IS; Czerwinski DK; Wechser MA; Levy R
Leukemia; 2003 Apr; 17(4):789-95. PubMed ID: 12682639
[TBL] [Abstract][Full Text] [Related]
25. Lymphotoxin beta expression is high in chronic lymphocytic leukemia but low in small lymphocytic lymphoma: a quantitative real-time reverse transcriptase polymerase chain reaction analysis.
Nagy B; Ferrer A; Larramendy ML; Galimberti S; Aalto Y; Casas S; Vilpo J; Ruutu T; Vettenranta K; Franssila K; Knuutila S
Haematologica; 2003 Jun; 88(6):654-8. PubMed ID: 12801841
[TBL] [Abstract][Full Text] [Related]
26. Loss of PIM2 enhances the anti-proliferative effect of the pan-PIM kinase inhibitor AZD1208 in non-Hodgkin lymphomas.
Kreuz S; Holmes KB; Tooze RM; Lefevre PF
Mol Cancer; 2015 Dec; 14():205. PubMed ID: 26643319
[TBL] [Abstract][Full Text] [Related]
27. bcl-1 rearrangement. Frequency and clinical significance among B-cell chronic lymphocytic leukemias and non-Hodgkin's lymphomas.
Athan E; Foitl DR; Knowles DM
Am J Pathol; 1991 Mar; 138(3):591-9. PubMed ID: 1900388
[TBL] [Abstract][Full Text] [Related]
28. Proto-oncogene expression in bovine peripheral blood leukemic lymphocytes during their spontaneous proliferation, differentiation and apoptosis in vitro.
Kalvelyte AV; Pabrezaite LC
Leuk Res; 1998 Feb; 22(2):135-43. PubMed ID: 9593470
[TBL] [Abstract][Full Text] [Related]
29. Correlation of transferrin receptor expression with histologic grade and immunophenotype in chronic lymphocytic leukemia and non-Hodgkin's lymphoma.
Das Gupta A; Shah VI
Hematol Pathol; 1990; 4(1):37-41. PubMed ID: 2187855
[TBL] [Abstract][Full Text] [Related]
30. High incidence of monosomy 18 in lymphoid malignancies that have bone marrow and peripheral blood involvement.
Younes A; Jendiroba D; Engel H; Escudier S; Katz R; Rodriguez MA; Hill D; Cabanillas F; Andreeff M
Cancer Genet Cytogenet; 1994 Oct; 77(1):39-44. PubMed ID: 7923081
[TBL] [Abstract][Full Text] [Related]
31. Activation-induced cytidine deaminase mRNA levels in chronic lymphocytic leukemia.
Hancer VS; Kose M; Diz-Kucukkaya R; Yavuz AS; Aktan M
Leuk Lymphoma; 2011 Jan; 52(1):79-84. PubMed ID: 21133730
[TBL] [Abstract][Full Text] [Related]
32. [mRNA levels detected by real-time quantitative RT-PCR in chronic lymphocytic leukemia and their clinical significance].
Liu L; Fang C; Dong HJ; Wang DM; Zhu DX; Qiao C; Fan L; Miao KR; Liu P; Xu W; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Oct; 19(5):1145-9. PubMed ID: 22040960
[TBL] [Abstract][Full Text] [Related]
33. Clonally rearranged antigen receptor gene DNA studies in evaluation of susceptibility of neoplastic lymphocytic and plasmacytic disorders to selective loss in long-term marrow culture.
Farag SS; Firkin FC
Leukemia; 1994 Aug; 8(8):1369-74. PubMed ID: 8057675
[TBL] [Abstract][Full Text] [Related]
34. Identification of genes whose expression patterns differ in benign lymphoid tissue and follicular, mantle cell, and small lymphocytic lymphoma.
Schmechel SC; LeVasseur RJ; Yang KH; Koehler KM; Kussick SJ; Sabath DE
Leukemia; 2004 Apr; 18(4):841-55. PubMed ID: 14961037
[TBL] [Abstract][Full Text] [Related]
35. Variation of LEF-1 mRNA expression in low-grade B-cell non-Hodgkin's lymphoma.
Howe D; Bromidge T
Leuk Res; 2006 Jan; 30(1):29-32. PubMed ID: 16054689
[TBL] [Abstract][Full Text] [Related]
36. miRNA analysis in B-cell chronic lymphocytic leukaemia: proliferation centres characterized by low miR-150 and high BIC/miR-155 expression.
Wang M; Tan LP; Dijkstra MK; van Lom K; Robertus JL; Harms G; Blokzijl T; Kooistra K; van T'veer MB; Rosati S; Visser L; Jongen-Lavrencic M; Kluin PM; van den Berg A
J Pathol; 2008 May; 215(1):13-20. PubMed ID: 18348159
[TBL] [Abstract][Full Text] [Related]
37. Richter's and prolymphocytic transformation of chronic lymphocytic leukemia are associated with high mRNA expression of activation-induced cytidine deaminase and aberrant somatic hypermutation.
Reiniger L; Bödör C; Bognár A; Balogh Z; Csomor J; Szepesi A; Kopper L; Matolcsy A
Leukemia; 2006 Jun; 20(6):1089-95. PubMed ID: 16541139
[TBL] [Abstract][Full Text] [Related]
38. New insights into the pathogenesis of chronic lymphocytic leukemia.
Klein U; Dalla-Favera R
Semin Cancer Biol; 2010 Dec; 20(6):377-83. PubMed ID: 21029776
[TBL] [Abstract][Full Text] [Related]
39. [Detection of bcl-2/JH gene rearrangements in non-Hodgkin's lymphomas and chronic tonsillitis, but not in Hodgkin's lymphomas. Molecular genetic and immunohistochemical study].
Nolte M; Werner M; Spann W; Schnabel B; von Wasielewski R; Wilkens L; Georgii A
Pathologe; 1993 Dec; 14(6):302-6. PubMed ID: 8121883
[No Abstract] [Full Text] [Related]
40. Blood transfusions and risk of non-Hodgkin's lymphoma subtypes and chronic lymphocytic leukemia.
Cerhan JR; Wallace RB; Dick F; Kemp J; Parker AS; Zheng W; Sellers TA; Folsom AR
Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):361-8. PubMed ID: 11319177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]